Japan's Taisho in lead to buy Paras Pharma

Japan's Taisho Pharmaceuticals has emerged the top bidder to buy a majority stake in Indian drugmaker Paras Pharmaceuticals, which owns popular brands such as anti-cold medication D'Cold and pain relieving ointment Moov, the Economic Times says. Report

Suggested Articles

AstraZeneca has signed a $750 million deal to produce up to 300 million doses of Oxford University's COVID-19 vaccine by year's end.

Moderna is entering an important time, its CEO says. And the company is doing so with a new finance chief from Big Biotech.

A new NEJM study found taking hydroxychloroquine after COVID-19 exposure doesn't reduce the risk of an infection. But questions remain.